Editorial Notice: NovaMedSpa.com is an independent wellness publication. We are not a medical spa, clinic, or healthcare provider. This content is for informational purposes only and does not constitute medical advice. Ingredient-level research does not establish efficacy for any specific finished product containing those ingredients.
Quick Answer: The active ingredients commonly used in micro-infusion serums — including sodium hyaluronate, hydrolyzed collagen peptides, acetyl hexapeptide-8 (Argireline), oligopeptide-1 (an EGF analog), and carnosine — each have individual published research profiles for skin applications. The critical delivery variable is whether the ingredient actually reaches its biological target. Most of these ingredients face significant penetration barriers when applied topically. Micro-channeling's theoretical advantage is bypassing that barrier, which makes ingredient selection and serum formulation more consequential, not less. This guide explains what each ingredient class does and how to evaluate a serum formula.
How to Read Supplement and Cosmetic Research
Before examining individual ingredients, the analytical framework matters — particularly for readers who have encountered ingredient marketing claims and want to assess them accurately.
Research exists at several levels, and each level tells you something different. In vitro studies (cell culture experiments) tell you what an ingredient can do in a controlled lab environment with direct cellular access. Animal studies add complexity but still don't translate directly to human skin behavior. Human clinical trials are the relevant standard for skincare claims — and within that category, there is a spectrum from small pilot studies to large randomized controlled trials (RCTs) to systematic reviews of multiple studies.
The additional variable for topical ingredients is delivery: what happens in a clinical study with professionally applied concentrations in a controlled setting may differ substantially from what a consumer achieves with an at-home product. The research establishing that sodium hyaluronate hydrates skin tells you about the ingredient. Whether a specific serum delivers that ingredient in effective concentrations to the right skin layer is a separate question that requires product-specific data. This distinction is why rigorous editorial content separates ingredient research from finished-product efficacy claims.
The Dose and Delivery Framework
For any ingredient applied to skin, two questions determine whether the research translates to real-world effect: Is the concentration sufficient? Does it reach its biological target?
The stratum corneum — the outermost skin layer — is the primary barrier to delivery. It is designed to keep things out, and it does this job effectively for most molecules, particularly large, hydrophilic ones. Molecular weight and charge are the primary determinants of topical penetration: smaller, more lipophilic molecules penetrate more readily; larger, more water-soluble molecules are largely blocked.
This delivery constraint is the reason micro-channeling devices have attracted legitimate interest in the skincare research community. By creating temporary channels through the stratum corneum, they allow ingredients that would otherwise accumulate on the surface to reach the viable epidermis and potentially the upper dermis. Research published in the Journal of Cosmetic Dermatology (Quinlan, Ghanem, and Hassan, 2022) evaluated home-based microneedling at 0.2mm combined with topical growth factor serum over three months in 11 women aged 33 to 61. The combination produced measurable improvements in skin texture, fine lines, and pigmentation scored by VISIA imaging analysis. The delivery mechanism amplified the serum's effect — the same ingredients without the micro-channeling component would have limited penetration to their biological targets.
Sodium Hyaluronate — Hydration and Barrier Support
Sodium hyaluronate is the sodium salt form of hyaluronic acid, a glycosaminoglycan naturally present throughout the skin's dermis. It is a humectant — a molecule that attracts and holds water — with the capacity to retain large amounts of moisture relative to its weight. The sodium hyaluronate form is typically processed to a smaller molecular weight than standard hyaluronic acid, which provides better penetration potential.
A randomized controlled trial by Pavicic and colleagues (2011), published in the Journal of Drugs in Dermatology, examined hyaluronic acid formulations across five molecular weights (50, 130, 300, 800, and 2,000 kDa) in 76 women aged 30 to 60 over 60 days. The study found that lower-molecular-weight formulations produced the most measurable improvements in skin hydration and the appearance of fine lines. The mechanism is straightforward: smaller molecules penetrate more effectively into the epidermis and can reach the viable tissue where they have humectant targets.
The delivery advantage of micro-channeling is potentially most pronounced for hyaluronic acid derivatives. High-molecular-weight HA applied topically largely remains on the surface; when channels exist, even larger HA molecules can access the epidermis directly. This makes HA arguably the ingredient class that benefits most from a micro-channel delivery approach, as it has robust evidence for skin hydration when it reaches its biological target and a clear delivery challenge when applied topically without barrier disruption.
Hydrolyzed Collagen — Peptide Delivery for Structural Support
Intact collagen cannot penetrate the skin — its molecular weight (300,000 kDa) is far too large for transdermal delivery by any non-invasive mechanism. Hydrolyzed collagen is a different matter: the protein is enzymatically broken into smaller peptide fragments with molecular weights typically in the range of 1,000 to 10,000 Da, which are more accessible for transdermal delivery.
These hydrolyzed peptide fragments function in skin applications not as structural collagen itself — they do not directly deposit into the extracellular matrix — but as signaling molecules. Collagen-derived peptides can stimulate fibroblast activity, encouraging the skin's own collagen-producing cells to increase synthesis. This is an indirect mechanism: the delivered peptides signal for more collagen production rather than adding collagen directly. The effect is more modest than direct collagen induction (as occurs with deep clinical microneedling) but is a real and studied mechanism.
The key variable is again delivery depth. Collagen-derived peptides that reach the dermis have fibroblast targets — the cells in the dermis responsible for producing extracellular matrix proteins. At 0.3mm depth, the primary delivery target is the viable epidermis, not the dermis. The epidermis does contain fibroblast precursors and keratinocytes that may respond to peptide signals, but the clinical data for this mechanism at shallow depths is less developed than for deeper clinical microneedling.
Acetyl Hexapeptide-8 — The Expression Line Peptide
Acetyl hexapeptide-8, widely marketed as Argireline, is a synthetic peptide that has been studied for its effect on expression lines — specifically the fine lines formed by repeated facial muscle contractions. Its proposed mechanism involves inhibiting the neuromuscular signaling cascade (specifically the SNARE protein complex) responsible for muscle contraction, with a superficial and limited analog to botulinum toxin's mechanism. The effect, where it occurs, is more subtle and localized than medical treatment.
A 2025 review in the International Journal of Molecular Sciences (Zdrada-Nowak, Surgiel-Gemza, and Szatkowska) examined the evidence for acetyl hexapeptide-8, noting that while studies suggest it may reduce wrinkle depth, its low skin penetration limits its bioavailability and therapeutic potential in standard topical applications. The researchers specifically emphasized the need for advanced delivery systems to optimize effectiveness — which speaks directly to the relevance of micro-channeling as a delivery approach. By bypassing the stratum corneum, the peptide potentially reaches the neuromuscular targets it needs to interact with at higher concentrations than topical application alone would achieve.
Oligopeptide-1 — The Growth Factor Analog
Oligopeptide-1 is a synthetic analog of epidermal growth factor (EGF), a protein that plays a role in regulating cell growth, proliferation, and differentiation. In skin applications, EGF analogs have been studied for their potential to stimulate keratinocyte proliferation (accelerating skin cell renewal), support wound healing, and contribute to a more uniform skin surface appearance.
The evidence base for growth factor delivery in skin care is reviewed in a systematic analysis by Quinlan, Ghanem, and Hassan (2023), covering 33 studies and 1,180 participants across 23 different topical growth factor preparations, which concluded that topical growth factor application is effective for facial skin rejuvenation, particularly when delivery is enhanced. The 2022 companion study specifically tested home-based microneedling at 0.2mm combined with growth factor serum and found measurable objective improvements in three months.
The delivery requirement is the key variable. EGF analogs are proteins with relatively high molecular weights, and their topical penetration without a delivery mechanism is limited. The micro-channeling rationale applies here: a growth factor that reaches the viable epidermis has targets (keratinocytes, growth factor receptors) that it cannot meaningfully access while sitting on the stratum corneum surface.
Carnosine — The Antioxidant Anchor
Carnosine is a naturally occurring dipeptide (beta-alanine and histidine) with well-documented antioxidant and anti-glycation properties. Glycation is a process in which sugars bind to proteins like collagen and elastin, forming advanced glycation end-products (AGEs) that make structural proteins stiff, less functional, and more prone to breakdown. Glycation is a contributing mechanism in skin aging and is distinct from the oxidative damage addressed by conventional antioxidants.
Carnosine's role in a micro-infusion serum is primarily as a protective co-ingredient. It is less likely to produce the visible skin changes associated with the peptide actives above, but its anti-glycation function addresses one of the ongoing processes that degrades existing collagen and elastin. In a serum context, its presence supports the condition for other ingredients to work more effectively over time by protecting the structural proteins they are intended to support.
How These Ingredients Work Together
The five verified serum actives in a formulation like Renewa's function through complementary mechanisms rather than a single pathway. Sodium hyaluronate provides immediate hydration and moisture retention in the delivered tissue. Hydrolyzed collagen peptides provide fibroblast-signaling input. Acetyl hexapeptide-8 addresses neuromuscular-driven expression lines where it can penetrate to target tissue. Oligopeptide-1 supports cell renewal processes. Carnosine protects existing structural proteins from glycation-related degradation.
The theoretical coherence of the formulation is reasonable — these are ingredients with individual research rationales that address different aspects of the skin aging picture described in detail in our companion article on how skin ages after 50. The critical question — whether this combination in this specific formulation delivers these ingredients at effective concentrations to their biological targets through a 0.3mm at-home device — requires product-specific clinical research that does not currently exist for the Renewa system specifically.
What This Means for Product Selection
When evaluating any micro-infusion serum — whether bundled with a device or purchased separately — the framework above suggests several practical questions. Does the formula contain ingredient classes with published research for skin applications (rather than only marketing buzzwords)? Are the actives' delivery challenges addressed by the mechanism the device provides? Is there any published clinical data specifically on the finished product, or only on the individual ingredients?
At-home skincare tools exist on a spectrum. The Renewa Micro-Infusion System uses a formulation with identifiable, researched actives (based on the verified serum fact disclosure from May 2026). At the other end, there are serums with ingredient lists full of botanicals or marketing terms without research backing. Applying the delivery-plus-evidence framework gives you a consistent basis for evaluation across products in this category, regardless of which brand you're considering.
For the same evidence-based evaluation framework applied to a different category of at-home skincare treatments, see our review of the Purely Me Mole Corrector Serum, which uses a similar ingredient-level evidence approach for a botanical formulation. For the verified product review of the Renewa Micro-Infusion System with pricing and refund terms, see our Article 1 product anchor. For safety guidance, see our at-home microneedling safety guide. For a device comparison, see our 2026 device comparison.
NovaMedSpa.com is an independent editorial publication. We are not a medical spa, clinic, or healthcare provider. The information on this site is for educational and informational purposes only and is not intended as medical advice. Ingredient-level research cited here does not establish efficacy for any specific finished product. Always consult a qualified healthcare provider before starting any skincare treatment.